From: Expiratory central airway collapse in stable COPD and during exacerbations
Healthy Individuals (n = 53) | Stable COPD (n = 40) | P value | |
---|---|---|---|
Age, years | 56.6 ± 16.9 | 70.1 ± 8.2 | <0.001 |
Sex, (female:male) | 18:35 | 21:19 | |
Body mass index (kg/m2) | 30.2 ± 7.0 | 28.7 ± 6.3 | 0.273 |
Pack years smoked | 9 ± 15 | 48.6 ± 39.5 | <0.001 |
FEV1 (% predicted) | 109 ± 17 | 65.7 ± 27.8 | <0.001 |
FEV1/FVC | 80 ± 10 | 55.4 ± 18.2 | <0.001 |
GOLD airflow limitation class (n) | N/A | I 11 II 14 III 11 IV 4 | n/a |
Bronchodilator response (% change) | 3 ± 4 | 8.9 ± 7.9 | <0.001 |
TLCO (% predicted) | 78 ± 15 | 51 ± 31.3 | <0.001 |
Medications (n) | |||
• Prednisolone 1-10 mg/d | 0 | 0 | n/a |
• Prednisolone >10 mg d | 0 | 2 | 0.099 |
• Inhaled CS < = budesonide 800 mg/d | 0 | 6 | 0.003 |
• Inhaled CS > 800 mg/d | 0 | 18 | <0.001 |
• LABA | 0 | 23 | <0.001 |
• LAMA | 0 | 22 | <0.001 |
Exacerbations requiring hospital admission in preceding year (n) | 0 | 0.1 ± 0.38 | <0.001 |